Table 3.
Predictors of intercostal muscle difference ratio ≥ 25% in follow-up of COVID-19 (R2 = 0.172, P = .006).
| Univariate regression analysis | Multivariate regression analysis | |||
|---|---|---|---|---|
| Adjusted odds ratio (95% confidence interval) | P value | Adjusted odds ratio (95% confidence interval) | P value | |
| Steroid | 3.300 (1.387–7.853) | .007* | 3.494 (1.419–8.604) | .007 |
| Follow-up ≥ 3 mo | 2.847 (1.312–6.175) | .008* | 3.006 (1.339–6.748) | .008 |
| Age < 65 yr | 2.097 (0.972–4.524) | .059 | ||
| Female | 2.226 (0.990–5.006) | .053 | ||
| Body mass index < 18.5 kg/m2 | 4.077 (0.441–37.705) | .216 | ||
| Mechanical ventilation | 1.042 (0.314–3.445) | .947 | ||
| Hospital stay > 13 d | 1.077 (0.510–2.275) | .846 | ||
| Intercostal muscle index | 1.933 (0.903–4.137) | .089 | ||
| Pectoralis muscle index | 2.083 (0.974–4.457) | .059 | ||
| T12 muscle index | 1.793 (0.841–3.824) | .131 | ||
T12 = thoracic 12th vertebra level.